Peripheral vascular disease in women: Are we analyzing the costs correctly?
Steven H BackWilliam A GrayPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
Women treated with a peripheral vascular intervention, on average, have more comorbidities and cost more per hospital admission than women treated with a percutaneous coronary intervention. The impact of critical limb ischemia on these results is likely significant, but not available in these data. Physicians need to be more aware of the differences in the risks and manifestations of cardiovascular disease in women.
Keyphrases
- polycystic ovary syndrome
- cardiovascular disease
- pregnancy outcomes
- percutaneous coronary intervention
- primary care
- emergency department
- healthcare
- type diabetes
- insulin resistance
- heart failure
- acute myocardial infarction
- atrial fibrillation
- metabolic syndrome
- skeletal muscle
- artificial intelligence
- human health
- coronary artery bypass grafting
- climate change
- antiplatelet therapy
- drug induced